Skip to content
Wenlo
Sign in
← Markets
After hours · Ends 8:00 PM ET

DHR Danaher Corp.

NYSE
$228.11−$4.12 (−1.77%)

As of 3:59:00 PM ET · 9 min old

Loading chart…

Open
$233.31
Previous close
$232.23
Day range
227.57 – 233.52
52-week range
160.93 – 242.80
Volume
144.4K
Avg volume (3M)
4M
Market cap
$163.3B
P/E (TTM)
38.46
EPS (TTM)
$6.04
Beta
0.80
Dividend yield
0.65%
Next earnings
—
Ex-dividend
Sep 30, 2026
Sector
Healthcare

About Danaher Corp.

Danaher Corp. is a global science and technology company focused on biotechnology, life sciences, and diagnostics. The company develops and supplies mission-critical tools, consumables, instruments, software, and services used in research, bioprocessing, clinical testing, and laboratory workflows. Its current business is organized around Biotechnology, Life Sciences, and Diagnostics, with offerings that support areas such as biologics manufacturing, molecular and clinical diagnostics, genomics, and analytical instrumentation. Danaher serves customers across healthcare, research, and industrial settings, helping laboratories and life sciences organizations improve efficiency, precision, and productivity. Headquartered in Washington, D.C., Danaher operates through a portfolio of specialized operating companies that provide products and solutions for scientific discovery, disease detection, and the production of biologic therapies.

DHR news and filings

Loading filings…

Filings from SEC EDGAR.